NCT04391075

Brief Summary

This study investigates efficacy, safety and childbirth experience in women receiving pudendal block during the final stage of delivery. It is an observational study and half of included primarous women recieve a pudendal block.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,007

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2019

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

May 12, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 18, 2020

Completed
Last Updated

May 19, 2020

Status Verified

May 1, 2020

Enrollment Period

2.3 years

First QC Date

May 12, 2020

Last Update Submit

May 15, 2020

Conditions

Keywords

Pudendal nerve blockUrine and urinationAnestheticsPeripheral nervous system agents

Outcome Measures

Primary Outcomes (2)

  • Childbirth experience

    Childbirth experience questionnaire (CEQ), total score on a scale from 1.0 to 4.0. Higher score means better experience.

    Responds to questionnaire 4-12 weeks after delivery.

  • Urinary retention

    Urinary retention after delivery defined as inability to void and need for catheterization within 3 hours.

    3 hours

Secondary Outcomes (1)

  • Pain, obstetric

    Responds to questionnaire 4-12 weeks after delivery.

Study Arms (2)

Exposed

Pudendal nerve block provided

Procedure: Pudendal nerve block

Not exposed

Pudendal nerve block is NOT provided

Interventions

Pudendal nerve block provided during last fase of delivery

Exposed

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The participants is selected from 2 delivery units at Oslo Univeristy Hospital (OUH) in Oslo, Norway. OUH is a third referral hospital, the largest Obstetrics Dept. in Norway, and accounting for 1/6 of all deliveries in Norway (9600 deliveries/year).

You may qualify if:

  • Norwegian-speaking/reading
  • Primiparity
  • Single pregnancy
  • Vaginal birth
  • Cephalic presentation
  • ≥37+0
  • Age ≥18 years

You may not qualify if:

  • Transferre from midwifery-led birth unit
  • Allergy to local anaesthesia
  • Not valid data on pudendal block

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Urinary RetentionPersonal SatisfactionLabor Pain

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesBehaviorPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Anne Flem Jacobsen, PhD

    Univeristy of Oslo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Midwife/PhD student

Study Record Dates

First Submitted

May 12, 2020

First Posted

May 18, 2020

Study Start

January 1, 2017

Primary Completion

May 1, 2019

Study Completion

May 31, 2019

Last Updated

May 19, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will share

Anonymous individual participant data for the primary outcome measures will be made available on request, when the study is finished. Access to data will be restricted due to sensitive nature of the data, but will be shared if asked for within the anonymous data restriction imposed by the patient consent and ethical body approval.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be available on request within 1 year after study completion.
Access Criteria
Data access will be considered on specific request. Requestors wil be required to sign a Data Access Agreement.